S Liang

Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study.

Robert A. Burger, Mark F. Brady, Michael A. Bookman et al. · Journal of Clinical Oncology · 2010 · 186 citations

Surgical Oncology, Ftc Patients, Lba1 Background +19

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

I. Shapira, Michaela Oswald, John L. Lovecchio et al. · British Journal of Cancer · 2013 · 150 citations · Full text

Frequent Expression of Napsin A in Clear Cell Carcinoma of the Endometrium

Oluwole Fadare, Mohamed Mokhtar Desouki, Krisztina Hanley et al. · The American Journal of Surgical Pathology · 2013 · 95 citations · Full text

Expression of Delta-Like Protein 4 in the Human Endometrium

James Mazella, S Liang, Linda Tseng · Endocrinology · 2007 · 36 citations · Full text

Delta Gene, Protein Function, Signal Transduction +15